DYAI Dyadic International, Inc.

NASDAQ
$0.78

Dyadic International, Inc. (DYAI) is expected to report earnings on November 11, 2026, after the market close. The consensus earnings estimate is a loss of $0.03 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -24.0% since its last earnings release on August 12, 2026.

Dyadic International Missed Consensus Estimates
Wednesday, August 12, 2026 · 8:30 AM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 11
Wednesday · 4:05 PM ET
Earnings Whisper
-
vs ($0.03)
Rev est $1.3M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $0.82

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Dyadic International, Inc.

Dyadic International, Inc. is a global biotechnology company which is developing what it believes will be a potentially significant biopharmaceutical gene expression platform based on the fungus Thermothelomyces heterothallica (formerly Myceliophthora thermophila), named C1.

Sector

Healthcare

Industry

Biotechnology